211 related articles for article (PubMed ID: 22633963)
1. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
John CS; Currie PJ
Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
3. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
Lee J; Di Marzo V; Brotchie JM
Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
[TBL] [Abstract][Full Text] [Related]
4. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.
Costa B; Bettoni I; Petrosino S; Comelli F; Giagnoni G; Di Marzo V
Pharmacol Res; 2010 Jun; 61(6):537-46. PubMed ID: 20138997
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.
Pardo-García TR; Yusif-Rodriguez N; Yudowski G; Maldonado-Vlaar CS
Neurosci Lett; 2020 Jul; 732():135023. PubMed ID: 32422166
[TBL] [Abstract][Full Text] [Related]
6. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
7. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei.
Moreira CM; Masson S; Carvalho MC; Brandão ML
Brain Res Bull; 2007 Mar; 71(5):466-74. PubMed ID: 17259015
[TBL] [Abstract][Full Text] [Related]
8. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala.
Dono LM; Currie PJ
Neuropharmacology; 2012 Jan; 62(1):192-9. PubMed ID: 21736884
[TBL] [Abstract][Full Text] [Related]
10. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
11. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
de Novellis V; Vita D; Gatta L; Luongo L; Bellini G; De Chiaro M; Marabese I; Siniscalco D; Boccella S; Piscitelli F; Di Marzo V; Palazzo E; Rossi F; Maione S
Mol Pain; 2011 Jan; 7():7. PubMed ID: 21241462
[TBL] [Abstract][Full Text] [Related]
12. GABA and histamine interaction in the basolateral amygdala of rats in the plus-maze test of anxiety-like behaviors.
Hajizadeh Moghaddam A; Roohbakhsh A; Rostami P; Heidary-Davishani A; Zarrindast MR
Pharmacology; 2008; 82(1):59-66. PubMed ID: 18477857
[TBL] [Abstract][Full Text] [Related]
13. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
Kokare DM; Dandekar MP; Chopde CT; Subhedar N
Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
[TBL] [Abstract][Full Text] [Related]
14. The analgesic effect of N-arachidonoyl-serotonin, a FAAH inhibitor and TRPV1 receptor antagonist, associated with changes in rostral ventromedial medulla and locus coeruleus cell activity in rats.
de Novellis V; Palazzo E; Rossi F; De Petrocellis L; Petrosino S; Guida F; Luongo L; Migliozzi A; Cristino L; Marabese I; Starowicz K; Di Marzo V; Maione S;
Neuropharmacology; 2008 Dec; 55(7):1105-13. PubMed ID: 18616956
[TBL] [Abstract][Full Text] [Related]
15. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.
Chegini HR; Nasehi M; Zarrindast MR
Behav Brain Res; 2014 Mar; 261():114-26. PubMed ID: 24333573
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system.
Zarrindast MR; Sroushi A; Bananej M; Vousooghi N; Hamidkhaniha S
Eur J Pharmacol; 2011 Dec; 672(1-3):106-12. PubMed ID: 21968140
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
18. Involvement of CB
Sartim AG; Moreira FA; Joca SRL
Neuroscience; 2017 Jan; 340():126-134. PubMed ID: 27771531
[TBL] [Abstract][Full Text] [Related]
19. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus.
Bambico FR; Duranti A; Nobrega JN; Gobbi G
Eur Neuropsychopharmacol; 2016 Mar; 26(3):578-90. PubMed ID: 26747370
[TBL] [Abstract][Full Text] [Related]
20. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
